- HETEROCYCLIC SULFONAMIDE DERIVATIVES
-
The present invention relates to compounds: and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases like cancer and inflammation.
- -
-
-
- HETEROCYCLIC SULFONAMIDE DERIVATIVES
-
The present invention relates to compounds (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases like cancer and inflammation.
- -
-
-
- HETEROCYCLIC SULFONAMIDE DERIVATIVES
-
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases (e.g., cancer and inflammation).
- -
-
Page/Page column 33-34
(2011/06/26)
-
- NOVEL MEK INHIBITORS, USEFUL IN THE TREATMENT OF DISEASES
-
The invention pertains to compound of Formula (I) wherein X, Y, Z, R1, R2, R3, R4, A and A' are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases
- -
-
Page/Page column 53-54
(2011/05/05)
-
- N-(ARYLAMINO)-SULFONAMIDE INHIBITORS OF MEK
-
This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
- -
-
Page/Page column 73; 74
(2008/06/13)
-
- N-ARYL-N'ALKYL SULFAMIDES AS MEK INHIBITORS
-
This invention concerns N-(ortho phenylaminoaryl), N′-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
- -
-
Page/Page column 46
(2008/06/13)
-